• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points

tetano

Editor, Senior Moderator
J Med Virol


. 2025 Jan;97(1):e70161.
doi: 10.1002/jmv.70161. Dynamic Changes and Trends of SARS-CoV-2 Antibodies Induced by Infection and Vaccination Across Multiple Time Points

Shihan Zhang[SUP] 1 2 [/SUP], Xiaoxiao Kong[SUP] 3 [/SUP], Qian Zhen[SUP] 4 [/SUP], Ye Wei[SUP] 5 [/SUP], Chao Shi[SUP] 6 [/SUP], Songning Ding[SUP] 7 [/SUP], Liling Chen[SUP] 8 [/SUP], Chen Dong[SUP] 3 [/SUP], Hua Tian[SUP] 3 [/SUP], Chuchu Li[SUP] 3 [/SUP], Lu Zhou[SUP] 3 [/SUP], Yazhen Zhang[SUP] 1 2 [/SUP], Fengcai Zhu[SUP] 3 [/SUP], Jianli Hu[SUP] 3 [/SUP], Changjun Bao[SUP] 3 [/SUP], Hui Jin[SUP] 1 2 [/SUP], Ke Xu[SUP] 3 [/SUP], Liguo Zhu[SUP] 3 9 10 [/SUP]



Affiliations
Abstract

As the COVID-19 pandemic continues, increasingly complex vaccination and infection histories have made it urgent to investigate the antibody dynamics in populations with hybrid immunity. This study aimed to explore the multi-time-point dynamics of SARS-CoV-2 IgG antibody levels in a community-based population in Jiangsu Province, China, following the Omicron BA.5 wave, as well as the long-term persistence of IgG antibodies nearly 2 years postinfection. A total of 2737 participants across Jiangsu Province were followed up at three different time points over a 6-month period (December 2022-June 2023). Additionally, a cross-sectional serological survey was conducted in October 2024, involving 230 participants to assess long-term antibody persistence. We used generalized additive models to fit antibody dynamics curves, generalized linear mixed models to explore factors influencing antibody levels, and Kaplan-Meier survival analysis to estimate cumulative seroreversion rates. Our findings revealed that, following the large-scale Omicron BA.5 infections, over 85% of the population initially exhibited seropositive IgG levels. Older individuals (> 65 years) had significantly lower antibody levels and faster rates of decline compared to younger participants. Booster immunization reduced the risk of seroreversion by 59.79% (95% CI: 29.63%-76.46%), while individuals with multiple infections experienced slower antibody decay. In the cross-sectional survey conducted 22 months postinfection, the IgG seropositivity rate remained high, exceeding 98%, indicating sustained immunity at the population level. This study provides valuable insights into the dynamics and persistence of IgG antibody levels following large-scale infection. The results underscore the importance of tailored booster immunization strategies to sustain long-term immunity, especially in vulnerable groups like the elderly. Additionally, ongoing serological monitoring is essential for assessing population immunity and informing future vaccination strategies.

Keywords: SARS‐CoV‐2 IgG dynamics; booster immunization; hybrid immunity; seroepidemiology.

 
Back
Top Bottom